Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles.
about
Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisationQuantum dots for tracking dendritic cells and priming an immune response in vitro and in vivoEffects of particle size on toll-like receptor 9-mediated cytokine profiles.Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactionsAntigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo.Multifunctional triblock copolymers for intracellular messenger RNA deliveryCross-presentation: underlying mechanisms and role in immune surveillance.Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.Real-time imaging of the cellular interactions underlying tolerance, priming, and responses to infection.The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cellsAdjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.Investigating the immunologic effects of CoCr nanoparticlesNano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.Liposomal vaccine delivery systems.Information processing during phagocytosis.Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Mechanisms of action of adjuvantsAn overview of adjuvant formulations and delivery systems.The impact of size on particulate vaccine adjuvants.Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.The Role of Lipids in Development of Allergic Responses.Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid.Uptake of ricinB-quantum dot nanoparticles by a macropinocytosis-like mechanism.Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.Time to cast a larger net.Efferocytosis of Pathogen-Infected Cells.Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing.The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines.Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses.Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes.Manufacturing Methods for Liposome Adjuvants.Discovery of a sugar-based nanoparticle universally existing in boiling herbal water extracts and their immunostimulant effectThe Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes
P2860
Q27316184-9A932BC3-9A77-451E-A377-9535BEDE2D46Q27438175-CA1C233C-3D94-4FC1-93FF-69789F731A4FQ34540279-BA27E5B8-FFE3-49D1-8417-DA3A0265479AQ34976001-12043E8E-FAD8-40DF-B6F2-863F94F93532Q36022467-1E0C8090-2D0E-4BBA-9EDE-3D9CABB6AABBQ36140780-04942F23-B7A1-4BD0-9CEE-952250D50BE6Q36266474-2C61C425-89D1-424A-AA92-EE5633B0FBB3Q36517179-9BB4ED68-478F-412F-9C3F-225DFCE1DC45Q37084889-5F063CED-5358-4C11-B4FF-B603B3AE504AQ37327058-4BEBB120-56B6-4FF5-8A13-962B9B8D1896Q37357786-CA525D5C-A775-4CCC-9F37-98DB19D7C9AFQ37380242-53AB2943-B982-4C57-8D6A-71628B1E7276Q37785952-2BF2FF5E-8086-4C84-8E10-6970CC7493ADQ37854063-B44088E7-485F-41BF-80F5-958F3AC4A420Q38018843-6E3979FA-B9D6-41DE-A783-2CE841869B2CQ38068245-0055A09B-45C6-4369-BF3B-D4521CA1AF30Q38110539-5FE1F2DF-065B-4DEA-8E29-4AECE90A357EQ38126953-5CEBE3CE-8303-4F6B-813C-794248ABA3A1Q38296080-34F97F92-640F-4128-99F1-805D1CEBFD51Q38757220-9090741C-1C60-42E8-9A58-21FD168FE06DQ39039132-1E97B28A-15DA-4AA0-B40E-BA52DADCA650Q39416443-C91345AA-283F-421E-8B5F-C5FD5FDB3963Q41678461-4DA64FA2-D654-4B10-84FC-8B5570E972A7Q41884496-322B26E7-F147-47D8-8306-FC041989A9DEQ42122881-2E41A036-7B7E-4FB4-A1D0-C839B6747CDDQ43128462-F8959EC8-64CF-4EFD-A9D4-C1576E0693C1Q46095609-5490508C-BFB1-4C13-B2B5-E3CD88955193Q47171468-56E22098-68F3-43C0-A816-B4ACEF07A9E6Q47253016-ADA218FD-AE02-415C-9654-C83EC771D878Q50124824-06F5D9EC-401A-41E3-A8E5-042ADBA1FE66Q50995525-8147A032-E666-44AF-B86D-1440C6FD5A7FQ52655238-B5BF481B-4EFD-4E50-B215-50ED4AFB09B0Q52714411-66ACBB3C-0C21-4B71-AA3D-1C52908BF4D0Q53127398-65769E46-16BB-46CA-8C4E-B0D3AA417248Q53260546-7E649AB7-5AD9-4431-BEA9-6E06654AF913Q54690087-1E43CF87-957B-450F-8387-7308713765E2Q58571693-67010C9A-DB96-4BE7-966E-364727D8F5ADQ59136982-A32CC60C-AE05-4099-BB35-5DB605276667
P2860
Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@en
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@nl
type
label
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@en
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@nl
prefLabel
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@en
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@nl
P1476
Vesicle size influences the tr ...... of antigens in lipid vesicles.
@en
P2093
David G Russell
Kevin G J Pollock
P304
P356
10.4049/JIMMUNOL.173.10.6143
P407
P577
2004-11-01T00:00:00Z